《亞洲股市》圓匯跌穿149關創近一年低 日經低收全日回吐363點或1.1%
雖然日本財務大臣鈴木俊一表示,政府高度關注外匯走勢,不排除採取任何措施來應對無序波動,但無助扭轉日圓弱勢。圓匯跌穿149關,創約十一個月低,美元兌日圓現報149.12。日經指數今早(26日)低開38點後跌幅擴大,更以全日最低位收報32,315,跌363點或1.1%;全日高低波幅328點。
主要銀行股午後轉升,瑞穗、三菱日聯、Resona控股反覆升0.7%至1%,三井住友則升1.6%。
權重股普遍偏軟,NTT及石油股ENEOS微跌0.1%至0.2%,迅銷、軟銀、樂天跌0.8%至1.1%,Z Holdings及神戶製鋼跌1.7%至2.7%。東電靠穩微升。主要車股豐田、日產及三菱汽車跌1%至2%。
半導體板塊跑輸,瑞薩電子、Sumco、太陽誘電、東京威力及Screen集團跌2.8%至3.8%。
部分醫藥股受壓,第一三共及衛材分別回吐4.3%及5.2%。日本厚生勞動省昨日(25日)正式批准了衛材和美國渤健(Biogen)(BIIB.US)共同開發的阿茲海默病治療藥Lecanemab。該藥是日本國內首款已證明可有效減緩病情發展速度的藥物。在確定藥物的官方定價之後,預計最早今年年內就能在日本的醫療一線使用。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.